Prevention and Control of Chronic Disease and Associated Risk Factors in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and P. R.
The purpose of this five-year program is to reduce the rates of disability and death associated with chronic disease in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and Puerto Rico. The U.S. Affiliated Pacific Islands include American Samoa, Commonwealth of the Northern Mariana Islands, Guam, Federated States of Micronesia, Republic of the Marshall Islands, and Republic of Palau. Evidence-based strategies to reduce tobacco use and secondhand smoke exposure, prevent and improve management of diabetes and cardiovascular disease (CVD), improve availability and quality of data to inform programs, including maternal and child health and oral health, and monitor progress will be supported. Cross-cutting and unified approaches to address chronic disease and their risk factors, with an emphasis on tobacco use, diabetes, CVD, maternal and child health, and oral health will be supported. The purpose of this program is: a) To reduce tobacco use and secondhand smoke exposure b) To improve prevention and management of diabetes c) To prevent persons at risk for pre-diabetes from developing diabetes d) To improve prevention and management of high blood pressure and high cholesterol e) To collect data to inform programs and policies that aim to improve maternal and child health f) To better address oral health needs
General information about this opportunity
Last Known Status
Active
Program Number
93.377
Federal Agency/Office
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Not applicable.
Authorization
Section 301(a) and 317(k)(2) of the Public Health Service Act, [42 U.S.C. Section 241(a) and 247b(k)(2)], as amended.
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Applicants must provide proof of ability to serve populations in one of the following jurisdictions: Commonwealth of the Northern Mariana Islands (CNMI), American Samoa, Guam, Federated States of Micronesia (FSM), Republic of the Marshall Islands (RMI), Republic of Palau, U.S. Virgin Islands, Puerto Rico
Beneficiary Eligibility
Northern Mariana Islands, American Samoa, Guam, Federated States of Micronesia, Republic of the Marshall Islands, Republic of Palau, U.S. Virgin Islands, Puerto Rico.
Credentials/Documentation
Costs under CDC financial assistance mechanisms are in accordance with 2 CFR ?200, as codified in 45 CFR ?75. Any required credentials and/or documentation will be identified in the NOFO to which applications are submitted.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable.
Application Procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Award Procedure
After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.
Deadlines
Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.
Approval/Disapproval Decision Time
From 120 to 180 days.
Appeals
Not applicable.
Renewals
From 120 to 180 days. The project period is 5-years with 12-month budget periods. Throughout the project period, CDC's commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports, in documented technical assistance, and in other relevant documented activities), and the determination that continued funding is in the best interest of the federal government.
How are proposals selected?
Phase I: All applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC National Center for Chronic Disease Prevention and Health Promotion and CDC OGS. Applicants must provide proof of ability to serve populations in American Samoa, Commonwealth of the Northern Mariana Islands, Guam, Federated States of Micronesia, Republic of the Marshall Islands, Republic of Palau, U.S. Virgin Islands, or Puerto Rico. Incomplete applications that do not meet the eligibility criteria will not advance to Phase II review. Phase II Review: This funding opportunity is comprised of two components - Core Component and Competitive Components. Core Component: The Core Component will support recipients to implement the strategies and activities as outline in the NOFO. Applicants must propose a comprehensive work plan that addresses the activities following broad Strategies indicated in the NOFO. Applicants for the Core Component will be evaluated based on the evaluation criteria as indicated in the NOFO. Competitive Components: This program has two competitive Component that will support maternal and child health and oral health activities. All applicants must apply for the Core Component in order to be considered for either (or both) of the Competitive Components. Only those successful applicants under the Core Component will be eligible for Competitive Component funding. Applicants must apply for competitive Component funding at the same time they make application for Core Component funding. Competitive components will be evaluated based on the evaluation criteria as indicated in the NOFO. Phase III Review: Applications submitted under the Core Component will be funded by score and rank as determined by the objective review panel. Applications submitted under the Competitive Component will be funded by score and rank determined by the objective review panel. The Selecting official shall rely on the rank order established by the objective review panel as the primary factor in making awards.
How may assistance be used?
Funds can be used to pay overhead, travel costs, and other expenses directly related to achievement of the strategies and activities identified to fulfill the obligations specified in the notice of funding. Funds can be used for salaries for personnel to plan, implement, monitor, and evaluate program activities; for contracts or agreements to implement and evaluate program activities, including assessments and convening coalitions; contracts or agreements with community-based organizations or coalitions to provide health education and lifestyle support programs, or to improve the health of the physical environment (for example to improve access to healthy food, physical activity, or decrease tobacco exposure); or other activities that promote or support healthy behaviors and improved health in the population. Funds can be used to pay for activities and supplies necessary to provide the services outlined here, including self-blood pressure monitoring equipment. Funds can be used to develop and maintain data collection systems to collect and report biomeasures and behavior information and for monitoring systems for chronic disease.
What are the requirements after being awarded this opportunity?
Reporting
Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award.
Auditing
Not applicable.
Records
In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Financial assistance is provided for a 12-month budget period with project periods of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award.
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Stacy De Jesus
4770 Buford Highway
Mail Stop F-80
Atlanta, GA 30341 USA
sdejesus@cdc.gov
Phone: 7704886393
Sheryl Heard
4770 Buford Hwy, NE
Atlanta, GA 30341 USA
slh3@cdc.gov
Phone: 7704882855
Financial Information
Account Identification
75-0943-0-1-550
Obligations
(Cooperative Agreements (Discretionary Grants)) FY 22$3,285,954.00; FY 23 est $3,283,508.00; FY 24 est $3,283,508.00; FY 21$3,283,508.00; FY 20$3,286,054.00; FY 19$3,286,054.00; FY 18 FY 17 -
Range and Average of Financial Assistance
Awards are expected to range from $250,000 to $1,500,000 (total award for both Core and Competitive Components, where applicable). All activities supported through this program must contribute to health improvements across the target population and across population subgroups. Funding strategy will also include the awardees' proposed activities and goals, estimated population reach, and program capacity as described in the application.
Regulations, Guidelines and Literature
Successful applicants must comply with the administrative requirements outlined in 45 Code of Federal Regulations (CFR) Part 75.
Examples of Funded Projects
Not applicable.